Cargando…

Not All Immune Checkpoints Are Created Equal

Antibodies that block T cell inhibition via the immune checkpoints CTLA-4 and PD-1 have revolutionized cancer therapy during the last 15 years. T cells express additional inhibitory surface receptors that are considered to have potential as targets in cancer immunotherapy. Antibodies against LAG-3 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Sousa Linhares, Annika, Leitner, Judith, Grabmeier-Pfistershammer, Katharina, Steinberger, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127213/ https://www.ncbi.nlm.nih.gov/pubmed/30233564 http://dx.doi.org/10.3389/fimmu.2018.01909

Ejemplares similares

PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
por: Stecher, Carmen, et al.
Publicado: (2017)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Not All Worms Were Created Equal
por: Loukas, Alex, et al.
Publicado: (2022)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents
por: Battin, Claire, et al.
Publicado: (2023)

TIM-3 Does Not Act as a Receptor for Galectin-9
por: Leitner, Judith, et al.
Publicado: (2013)

A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors
por: Tobias, Joshua, et al.
Publicado: (2020)

Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal
por: Ferrante, Andrea
Publicado: (2013)

A cellular platform for the evaluation of immune checkpoint molecules
por: Jutz, Sabrina, et al.
Publicado: (2017)

Not all vinculins are created equal
por: Leslie, Mitch
Publicado: (2014)

Neuropilin-1 Acts as a Receptor for Complement Split Products
por: Battin, Claire, et al.
Publicado: (2019)

T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells
por: Leitner, Judith, et al.
Publicado: (2010)

Not all nuclear pores created equal
por: Leslie, Mitch
Publicado: (2010)

All Purkinje cells are not created equal
por: Albergaria, Catarina, et al.
Publicado: (2014)

Not all P waves are equally created
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Are all antibiotic persisters created equal?
por: Shultis, Michael W., et al.
Publicado: (2022)

"ALL ANTIDEPRESSANTS ARE CREATED EQUAL" (SOME ARE MORE EQUAL THAN OTHERS)
por: Doongaji, Dinshaw R
Publicado: (2000)

Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)

Relative Specificity: All Substrates Are Not Created Equal
por: Zeng, Yan
Publicado: (2014)

Reply: Not all incomplete revascularizations are created equal
por: Weiss, Aaron J., et al.
Publicado: (2021)

LBMON273 Not All Men Are Created Equal
por: van Rooyen, Desmaré, et al.
Publicado: (2022)

Are all metachronous multifocal urothelial carcinoma created equal?
por: Reis, Leonardo O.
Publicado: (2018)

Inhibition of EGFR Signaling: All Mutations Are Not Created Equal
por: Gazdar, Adi F, et al.
Publicado: (2005)

Clustered ERF Transcription Factors: Not All Created Equal
por: Yuan, Ling
Publicado: (2020)

Not All EGFR Exon 20 Insertions Are Created Equal
por: Lin, Yen-Ting, et al.
Publicado: (2020)

RAAS inhibitors in COVID-19: not all are created equal!
por: Kow, Chia Siang, et al.
Publicado: (2023)

Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others
por: Rivière, Jennifer, et al.
Publicado: (2023)

Low seroprotection rate for meningococcus serogroup C in the adult HIV-1-infected population in Austria
por: Grabmeier-Pfistershammer, Katharina, et al.
Publicado: (2019)

Passive immunotherapy of sepsis with intravenous immune globulin: not all IVIg preparations are created equal
por: Vassilev, Tchavdar, et al.
Publicado: (2012)

Interrogating ligand-receptor interactions using highly sensitive cellular biosensors
por: Funk, Maximilian A., et al.
Publicado: (2023)

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
por: Griss, Johannes, et al.
Publicado: (2019)

Adolescent girls in context: Not all patterns may be created equal
por: Trost, Kari, et al.
Publicado: (2018)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Are all n-3 polyunsaturated fatty acids created equal?
por: Anderson, Breanne M, et al.
Publicado: (2009)

All (C57BL/6) Mice are not Created Equal
por: Kiselycznyk, Carly, et al.
Publicado: (2011)

The AKI care bundle: all bundle components are created equal—are they?
por: von Groote, Thilo C., et al.
Publicado: (2021)

Not all Radiofrequency Devices Are Created Equal: A Thermal Assessment
por: Dayan, Erez, et al.
Publicado: (2022)

Reply to: RAAS inhibitors in COVID-19: not all are created equal!
por: Gonçalves, Jorge, et al.
Publicado: (2023)

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency
por: Göschl, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4tglkhebt1tf70u37jbeiugfcj